{"id":30553,"date":"2020-01-28T00:00:00","date_gmt":"2020-01-28T00:00:00","guid":{"rendered":"http:\/\/medgoo.com\/index.php\/2020\/01\/28\/drug-price-fixing-charge-laid-against-pharma-bro-martin-shkreli\/"},"modified":"2020-01-29T17:10:07","modified_gmt":"2020-01-29T17:10:07","slug":"drug-price-fixing-charge-laid-against-pharma-bro-martin-shkreli","status":"publish","type":"post","link":"https:\/\/medgoo.com\/index.php\/2020\/01\/28\/drug-price-fixing-charge-laid-against-pharma-bro-martin-shkreli\/","title":{"rendered":"Drug Price-Fixing Charge Laid Against &#8216;Pharma Bro&#8217; Martin Shkreli"},"content":{"rendered":"<h3>Former drug industry executive charged with restricting competition to maintain a monopoly on the drug Daraprim<\/h3>\n<p><b><\/b><\/p>\n<p><b><\/b><\/p>\n<p>TUESDAY, Jan. 28, 2020 (HealthDay News) &#8212; So-called &#8220;Pharma Bro&#8221; Martin Shkreli faces charges of price fixing of a drug used to treat the potentially fatal condition toxoplasmosis.<\/p>\n<p>The former drug industry executive and Vyera Pharmaceuticals have been charged with allegedly restricting competition to maintain a monopoly on the drug Daraprim, the U.S. Federal Trade Commission said Monday, <i>CBS News<\/i> reported.<\/p>\n<p>Former drug industry executive Kevin Mulleady and Phoenixus AG, Vyera&#8217;s parent company, are also charged.<\/p>\n<p>Shkreli, currently serving a seven-year sentence for securities fraud, became notorious in the United States after his company, Turing Pharmaceuticals, bought the U.S. rights to Daraprim and then boosted the drug&#8217;s price by about 4,000 percent to $750 a pill.<\/p>\n<p><a href=\"https:\/\/www.cbsnews.com\/news\/martin-shkreli-sued-ftc-new-york-attorney-general-vyera-pharmaceuticals-illegally-monopolizing-drug-daraprim\/\" target=\"_new\" rel=\"noopener noreferrer\"><i>CBS News<\/i> Article<\/a><\/p>\n<p><i><\/i><\/p>\n<p><i>Copyright \u00a9 2020 <a href=\"https:\/\/www.healthday.com\/\" target=\"_new\" rel=\"noopener noreferrer\">HealthDay<\/a>. All rights reserved.<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Former drug industry executive charged with restricting competition to maintain a monopoly on the drug Daraprim<\/p>\n","protected":false},"author":6,"featured_media":30571,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[11],"class_list":["post-30553","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"_links":{"self":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/30553","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/comments?post=30553"}],"version-history":[{"count":0,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/30553\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media\/30571"}],"wp:attachment":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media?parent=30553"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/categories?post=30553"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/tags?post=30553"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}